Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Observation of human retinal remodeling in octogenarians with a resveratrol based nutritional supplement.

Richer S, Stiles W, Ulanski L, Carroll D, Podella C.

Nutrients. 2013 Jun 4;5(6):1989-2005. doi: 10.3390/nu5061989.

PMID:
23736827
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.

PMID:
17186262
[PubMed - indexed for MEDLINE]
3.

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.

Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C.

Optometry. 2011 Nov;82(11):667-680.e6. doi: 10.1016/j.optm.2011.08.008.

PMID:
22027699
[PubMed - indexed for MEDLINE]
4.

A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization.

Nussenblatt RB, Byrnes G, Sen HN, Yeh S, Faia L, Meyerle C, Wroblewski K, Li Z, Liu B, Chew E, Sherry PR, Friedman P, Gill F, Ferris F 3rd.

Retina. 2010 Nov-Dec;30(10):1579-87. doi: 10.1097/IAE.0b013e3181e7978e.

PMID:
20847709
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].

Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.

Ophthalmologe. 2008 Feb;105(2):158-64. German.

PMID:
17653552
[PubMed - indexed for MEDLINE]
6.

Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.

Aggio FB, Farah ME, Silva WC, Melo GB.

Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):215-20.

PMID:
17139490
[PubMed - indexed for MEDLINE]
7.

Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.

Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92. doi: 10.1007/s00417-012-1955-2. Epub 2012 Feb 21.

PMID:
22350060
[PubMed - indexed for MEDLINE]
8.

Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.

Retina. 2007 Jun;27(5):535-40.

PMID:
17558313
[PubMed - indexed for MEDLINE]
9.

One-year outcomes of less frequent bevacizumab in age-related macular degeneration.

Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS.

Retina. 2011 Apr;31(4):645-53. doi: 10.1097/IAE.0b013e3182012d18.

PMID:
21358363
[PubMed - indexed for MEDLINE]
10.

[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].

Lommatzsch A, Heimes B, Gutfleisch M, Spital G, Dietzel M, Pauleikhoff D.

Ophthalmologe. 2011 Mar;108(3):244-51. doi: 10.1007/s00347-010-2221-9. German.

PMID:
20571805
[PubMed - indexed for MEDLINE]
11.

Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

Keane PA, Patel PJ, Ouyang Y, Chen FK, Ikeji F, Walsh AC, Tufail A, Sadda SR.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5431-7. doi: 10.1167/iovs.09-4846. Epub 2010 Jun 16.

PMID:
20554607
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.

Punjabi OS, Huang J, Rodriguez L, Lyon AT, Jampol LM, Mirza RG.

Br J Ophthalmol. 2013 Aug;97(8):1024-31. doi: 10.1136/bjophthalmol-2013-303155. Epub 2013 Jun 12.

PMID:
23759437
[PubMed - indexed for MEDLINE]
13.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
[PubMed - indexed for MEDLINE]
14.

Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (avastin) therapy.

Prager F, Michels S, Simader C, Geitzenauer W, Schmidt-Erfurth U.

Retina. 2008 May;28(5):682-8. doi: 10.1097/IAE.0b013e318161dc70. Erratum in: Retina. 2008 Oct; 28(8):1178.

PMID:
18463510
[PubMed - indexed for MEDLINE]
15.

Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.

Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W.

Eye (Lond). 2009 Mar;23(3):694-702. doi: 10.1038/sj.eye.6703098. Epub 2008 Feb 1.

PMID:
18239678
[PubMed - indexed for MEDLINE]
16.

Intravitreal tumor necrosis factor-alpha inhibitors for neovascular age-related macular degeneration suboptimally responsive to antivascular endothelial growth factor agents: a pilot study from the Pan American Collaborative Retina Study Group.

Wu L, Arevalo JF, Hernandez-Bogantes E, Regatieri CV, Roca JA, Farah ME.

J Ocul Pharmacol Ther. 2013 Apr;29(3):366-71. doi: 10.1089/jop.2012.0203. Epub 2012 Dec 5.

PMID:
23215543
[PubMed - indexed for MEDLINE]
17.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

Mitry D, Bunce C, Charteris D.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD009510. doi: 10.1002/14651858.CD009510.pub2. Review.

PMID:
23440840
[PubMed - indexed for MEDLINE]
18.

Retinal spectral domain optical coherence tomography in early atrophic age-related macular degeneration (AMD) and a new metric for objective evaluation of the efficacy of ocular nutrition.

Richer S, Cho J, Stiles W, Levin M, Wrobel JS, Sinai M, Thomas C.

Nutrients. 2012 Nov 27;4(12):1812-27. doi: 10.3390/nu4121812.

PMID:
23363992
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors.

Veritti D, Sarao V, Lanzetta P.

J Ocul Pharmacol Ther. 2013 May;29(4):437-41. doi: 10.1089/jop.2012.0173. Epub 2012 Dec 6.

PMID:
23215753
[PubMed - indexed for MEDLINE]
20.

Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

Lazic R, Gabric N.

Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):68-73. Epub 2006 Nov 18.

PMID:
17111146
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk